1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Pulmonary Embolism-Pipeline Insights, 2014

Pulmonary Embolism-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Pulmonary Embolism-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pulmonary Embolism. This report provides information on the therapeutic development based on the Pulmonary Embolism dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Pulmonary Embolism
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Pulmonary Embolism pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Pulmonary Embolism and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Pulmonary Embolism
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Pulmonary Embolism pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Pulmonary Embolism-Pipeline Insights, 2014
Table of Contents
- Pulmonary Embolism Overview
- Pulmonary Embolism Pipeline Therapeutics
- Pulmonary Embolism Therapeutics under Development by Companies
- Pulmonary Embolism Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Pulmonary Embolism Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Pulmonary Embolism Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Pulmonary Embolism Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Pulmonary Embolism - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Pulmonary Embolism - Discontinued Products
- Pulmonary Embolism - Dormant Products
- Companies Involved in Therapeutics Development for Pulmonary Embolism
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Pulmonary Embolism, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Pulmonary Embolism Assessment by Monotherapy Products
- Pulmonary Embolism Assessment by Combination Products
- Pulmonary Embolism Assessment by Route of Administration
- Pulmonary Embolism Assessment by Stage and Route of Administration
- Pulmonary Embolism Assessment by Molecule Type
- Pulmonary Embolism Assessment by Stage and Molecule Type
- Pulmonary Embolism Therapeutics - Discontinued Products
- Pulmonary Embolism Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Pulmonary Embolism, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Pulmonary Embolism Assessment by Monotherapy Products
- Pulmonary Embolism Assessment by Combination Products
- Pulmonary Embolism Assessment by Route of Administration
- Pulmonary Embolism Assessment by Stage and Route of Administration
- Pulmonary Embolism Assessment by Molecule Type
- Pulmonary Embolism Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Diabetic Shoes Market Research Report 2016

Global Diabetic Shoes Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Diabetic Shoes Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetic Shoes industry, focusing on the main regions (North ...

Global Varicose Veins Laser Treatmen Equipment Market Research Report 2016

Global Varicose Veins Laser Treatmen Equipment Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Varicose Veins Laser Treatmen Equipment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Varicose Veins Laser Treatmen Equipment ...

Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.